3:35 1. Barbell the book — compounders vs call-options, sized by rule
The repeatable method
- Split the portfolio into two buckets: a slug of cheap, cash-generating, growing compounders, and a bucket of high-variance bets treated like call options (warrants, LEAPs, or pre-revenue early-stage names).
- Enter the option-like names small (2–3%) and let winners run; manage risk through position sizing, not stop-losses.
- When the option bucket balloons (a few names go up multiples), don't add — "rob from Peter to pay Paul," trimming to keep neither bucket out of whack.
- Be "ruthless about never adding to" an options position — the going-to-zero probability is real and ever-present.
Here: ~half his names had a 40–50% drawdown at some point this year and he treats that as par for the course; the early-stage sleeve (MRLN) is sized like VC while the cash-flow sleeve anchors the book.
Watch for
- Any single high-variance name drifting to a double-digit weight — the signal to trim, not add.
11:22 2. Underwrite the multi-year DCF — isolate the one variable that matters
The repeatable method
- Judge risk-reward against the outlook one-to-three years out, not today; a company is worth its multi-year future cash flow, not the next 12 months.
- Separate structural from cyclical: identify the one multi-year swing variable and largely ignore near-term noise around it.
- Weight your attention to risks that "permeate beyond a 12-month horizon"; near-term uncertainty is usually already in the price.
Here: for LIB he cared about the structural lithium-supply risk (the "sodium" question) over near-term "indigestion," and bought before lithium re-rated — the multi-year thesis, not the next few months.
Watch for
- Names where the bear case is purely near-term (timing, one quarter) while the multi-year economics are intact — that's a mispriced clock, not a broken thesis.
13:45 3. Avoid reflexive cash-burners — map the funding ladder
The repeatable method
- Screen out explorers and pre-cash-flow names where the next step must be funded by raising capital — a missed milestone makes dilution reflexive (low price → bigger raise → more dilution).
- If you do own one, map every funding step and the "timer" on it; a screw-up at any step compounds.
- Prefer businesses already generating cash or with assets they can sell to self-fund the next step.
Here: the whole thesis on LODE rests on cash coming "through the door" (the mining-claim sale) to kill the dilution "bogeyman" before the next metals/real-estate step.
Watch for
- A depressed market cap colliding with a near-term capital need — the setup that "hurts even more" if it goes wrong.
30:37 4. Asset-coverage — get the operating business (and its options) for free
The repeatable method
- Value the saleable / independent assets on their own (here: the land, the mining claims) against the whole enterprise value.
- If the cash those assets could realize approaches or exceeds the entire EV, you're buying the operating business — plus any call options — for nothing.
- Then the only thing you must underwrite is that the "free" business clears a low bar (doesn't burn cash / reaches profitability), with the scale of the upside as the debate.
Here: the LODE land alone is plausibly worth more than the market cap, so at ~$4 "you're virtually getting metals for free" — plus the LODE Bioleum lottery ticket on top.
Watch for
- A monetizable hard asset (real estate, claims, a stake) whose conservative value brackets the whole EV — the margin of safety under an option-rich story.
36:40 5. The vertical-integration test — does it capture the refining step?
The repeatable method
- For a recycling/processing business, ask where the economics leak: shipping intermediate product to a third-party refiner can hand away half the margin.
- Reward in-house refining/extraction — it lets the tipping fee be cut hard while protecting unit economics, and forces any competitor to solve both the processing plant and the refining (a double moat).
- Distinguish "does it work at all" (de-risked once a pilot runs) from "how profitable does it scale" — the latter is where the multi-bagger lives.
Here: LODE's in-house extraction (vs shipping to refiners in Brazil/Korea/China) is the durability case — one site at 70–80% utilization already makes the stock cheap; new sites are "a cherry on top."
Watch for
- Processing plays that quietly give up the refining margin — and the ones moving a pilot to demonstration scale to keep it.
43:25 6. The financing-unlock catalyst — the offtake re-rates the capital stack
The repeatable method
- For a pre-scale producer, recognize the re-rating trigger is rarely the product — it's securing an offtake that unlocks cheaper capital.
- An offtake enables project-level debt (instead of diluting at the parent), pref financing that can convert at a later up-listing, and a lower cost of capital from a US listing / re-domicile.
- Grade the offtake's shape: a multi-year deal with floor pricing (uranium-style) is worth far more than a rolling three-month spot arrangement.
- Treat sizable government (e.g. DOE) funding as an upside option you don't rely on.
Here: LIB's whole risk profile hinges on the offtake structure and a US uplisting cutting the cost of capital; the floor-price terms are what let it command a sticky, long-duration multiple.
Watch for
- The offtake announcement and its terms (floor vs spot, duration); a US listing / re-domicile and any DOE award as cost-of-capital step-changes.
53:31 7. The listed-VC / de-SPAC screen — find the good cohort, read the signals
The repeatable method
- Start from the base rate: 90%+ of de-SPACs are terrible — hunt the small cohort that are (or could be) genuinely good businesses.
- Demand a big-TAM, disruptive first-mover with a structural edge (platform-agnostic, not a me-too).
- Read the insider signal: zero insiders selling — better, insiders/private owners buying as they move into the listed sphere (the opposite of the usual SPAC cash-out).
- Take incumbents partnering instead of self-building as third-party validation and de-risking.
- Then size it like venture: small, expect dilution / drawdowns / delays, and be prepared to hold 3–5 years.
Here: MRLN ticks every box — platform-agnostic first-mover, GE/GD/Honeywell + DOD partners, zero insider selling — the same pattern that worked on ASTS ($1bn → ~$40–50bn).
Watch for
- De-SPACs with founder-led ownership, insider buying and incumbent partnerships — and the "hair" (convertible prefs, re-strikes) that defines the real downside.
59:14 8. The dual-use adoption sequence — fund on defense, dream on commercial
The repeatable method
- For dual-use tech, recognize the military steps up first — bankrolling, partnering and de-risking the product.
- Underwrite the base case on the funded defense pathway that's in front of you; treat the larger, slower commercial market as the "lottery ticket," not the base case.
- Favor AI that delivers visible value behind real barriers — AI fused with physical product and a long regulatory lead time is hard to replicate.
Here: MRLN mirrors ASTS — defense funds it now, commercial aviation is the upside; the regulatory lead time + physical retrofit is the moat.
Watch for
- Dual-use names where the defense contract funds the build and the commercial TAM is the free option.
1:01:40 9. Probability-weighted bear/base/bull — with an honest $0 bear
The repeatable method
- Write explicit bear / base / bull scenarios and assign probabilities, not a single price target.
- For near-binary names, recognize that small shifts in those probabilities move the equity a lot — so size accordingly.
- Always define the genuine zero: read the capital structure for the "hair" (convertible prefs that sit over the equity, re-strikes that lift the share count) that makes a real $0 bear.
Here: MRLN is framed as a 30–50x+ bull (100x with commercial) against a true-zero bear, with convertible prefs and a September-ADV re-strike as the downside "hair."
Watch for
- Convertible prefs, re-strike triggers and ADV-linked dilution clauses — the difference between a "high bear" and a real zero.
7:55 10. Scale against the froth — take risk off when you feel most bullish
The repeatable method
- On really frothy days, "scale away from what you're feeling" — if you feel super bullish, that's when to take some risk off.
- For options specifically, scale out after a large run while they're still out-of-the-money, because the volatility premium is rich and reverses fast.
- Keep it personal: match the cut to your own risk tolerance and "sleeping level."
Here: the LODE $7.50 December calls ran +200–250% on directors-buying news; he flagged scaling out before they "cratered" that Friday.
Watch for
- A parabolic, news-driven move in an out-of-the-money option — the moment to scale out, not add.
Methods distilled from the members-only Contrarian Codex Patreon video (transcript in transcript.txt) for personal study. Not investment advice. © Contrarian Codex / Uzo Capital for source material.